BTG To Pay Up To $475M For Emphysema Treatment Maker

By Igor Kossov ( December 4, 2014, 2:32 PM EST) -- U.K. health care company BTG plc on Thursday said it would pay up to $475 million to acquire interventional pulmonology company PneumRX Inc., seeking to expand its own pulmonology business with the target company's lung treatment devices. ...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!